Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells - 30/09/09
Corresponding author. Tel.: +48 61 854 6519; fax: +48 618546510.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
The CXCR4 chemokine receptor is a seven transmembrane G protein-coupled receptor present on the surface of various cells including cancer cells. The CXCR4 receptor contributes to the induction of several intracellular signalling pathways that enhance survival, proliferation, and migration of malignant cells.
We observed that tamoxifen (Tam) reduced the CXCR4 transcript and protein levels in MCF-7 breast cancer cells. However, we did not see a Tam effect on CXCR4 transcript and protein levels in MCF-7LVMT3B cells with RNA interference-mediated knockdown of DNMT3B. We also observed that Tam significantly increased, for several hours, the expression of enzymatically active DNMT3B splice variants in MCF-7 cells. However, there was no Tam effect on these DNMT3B splice variants’ expression in MCF-7LVMT3B cells. Bisulfite sequencing suggests that Tam may reduce CXCR4 expression via increased methylation of cytosine in the cytosine–guanosine (CpG) dinucleotide island of the CXCR4 promoter of MCF-7 breast cancer cells.
Our findings suggest that Tam induces an increase in DNMT3B expression that is associated with the increase of CpG dinucleotide methylation in the CXCR4 promoter and significant reduction of CXCR4 gene expression in MCF-7 cells.
Le texte complet de cet article est disponible en PDF.Keywords : CXCR4, Tamoxifen, DNA methyltransferases
Plan
Vol 63 - N° 8
P. 586-591 - septembre 2009 Retour au numéro
Article précédent
- Screening of potential prodrugs on cells derived from Dupuytren’s disease patients
- Sandra Kraljevic Pavelic, Sinisa Bratulic, Karlo Hock, Davor Jurisic, Marijana Hranjec, Grace Karminski-Zamola, Biserka Zinic, Maro Bujak, Kresimir Pavelic
- Protective effects of transgene expressed human PON3 against CCl4-induced subacute liver injury in mice
- Wei Peng, Xiaoling Jiang, Lv Haiqin, Chi Zhang, Jie Zhu, Junfeng Zhang, Yuhui Zang, Junchuan Qin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?